P. O’Connor

1.7k total citations
16 papers, 1.0k citations indexed

About

P. O’Connor is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, P. O’Connor has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 4 papers in Oncology and 3 papers in Neurology. Recurrent topics in P. O’Connor's work include Multiple Sclerosis Research Studies (9 papers), Polyomavirus and related diseases (3 papers) and Systemic Sclerosis and Related Diseases (2 papers). P. O’Connor is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Polyomavirus and related diseases (3 papers) and Systemic Sclerosis and Related Diseases (2 papers). P. O’Connor collaborates with scholars based in Canada, United States and Switzerland. P. O’Connor's co-authors include Amit Bar‐Or, Christian Confavreux, Melanie R. Ursell, M. S. Freedman, George P. Rice, D. W. Paty, Jeffrey A. Stewart, Richard D. Scheyer, Samantha Kimball and H. M. Dosch and has published in prestigious journals such as Neurology, Journal of Immunological Methods and Journal of the Neurological Sciences.

In The Last Decade

P. O’Connor

16 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. O’Connor Canada 10 783 242 233 221 152 16 1.0k
Claire Hirst United Kingdom 15 900 1.1× 189 0.8× 238 1.0× 374 1.7× 267 1.8× 27 1.2k
Suzanne Gazda United States 9 621 0.8× 225 0.9× 362 1.6× 273 1.2× 166 1.1× 13 1.0k
C. H. Polman Netherlands 10 788 1.0× 252 1.0× 156 0.7× 372 1.7× 265 1.7× 13 912
Gillian Ingram United Kingdom 18 964 1.2× 185 0.8× 388 1.7× 346 1.6× 299 2.0× 38 1.3k
Anton Vladić Croatia 12 452 0.6× 190 0.8× 199 0.9× 218 1.0× 141 0.9× 26 726
Robert Glanzman United States 9 529 0.7× 156 0.6× 292 1.3× 354 1.6× 128 0.8× 14 1.1k
Benjamin Turner United Kingdom 14 687 0.9× 239 1.0× 87 0.4× 298 1.3× 195 1.3× 42 933
Nebojša Stojsavljević Serbia 19 702 0.9× 127 0.5× 176 0.8× 218 1.0× 257 1.7× 34 1.0k
K. P. Johnson United States 8 882 1.1× 365 1.5× 589 2.5× 363 1.6× 356 2.3× 12 1.6k
Fady Joseph United Kingdom 14 474 0.6× 128 0.5× 124 0.5× 365 1.7× 309 2.0× 23 1.0k

Countries citing papers authored by P. O’Connor

Since Specialization
Citations

This map shows the geographic impact of P. O’Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. O’Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. O’Connor more than expected).

Fields of papers citing papers by P. O’Connor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. O’Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. O’Connor. The network helps show where P. O’Connor may publish in the future.

Co-authorship network of co-authors of P. O’Connor

This figure shows the co-authorship network connecting the top 25 collaborators of P. O’Connor. A scholar is included among the top collaborators of P. O’Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. O’Connor. P. O’Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Foley‐Nolan, D., et al.. (2020). Low energy high frequency pulsed electromagnetic therapy for acute whiplash injuries. A double blind randomized controlled study.. Journal of Rehabilitation Medicine. 24(1). 51–59. 1 indexed citations
2.
Antel, Jack P., Xavier Montalbán, P. O’Connor, et al.. (2012). Long-Term (7-Year) Data from a Phase 2 Extension Study of Fingolimod in Relapsing Multiple Sclerosis (P01.129). Neurology. 78(Meeting Abstracts 1). P01.129–P01.129. 6 indexed citations
3.
Kappos, L, EW Radue, P. O’Connor, et al.. (2012). Long-Term Efficacy and Safety of Fingolimod (FTY720) in Relapsing-Remitting Multiple Sclerosis (RRMS): Results from the Extension of the Phase III FREEDOMS Study (S41.004). Neurology. 78(Meeting Abstracts 1). S41.004–S41.004. 10 indexed citations
4.
Freedman, M. S., P. O’Connor, J. S. Wolinsky, et al.. (2012). Teriflunomide Increases the Proportion of Patients Free from Disease Activity in the TEMSO Phase III Study (PD5.007). Neurology. 78(Meeting Abstracts 1). PD5.007–PD5.007. 12 indexed citations
5.
Kimball, Samantha, Reinhold Vieth, Amit Bar‐Or, et al.. (2010). A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology. 74(23). 1852–1859. 273 indexed citations
6.
Hutchinson, Michael, Ludwig Kappos, Peter A. Calabresi, et al.. (2009). The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL. Journal of Neurology. 256(3). 405–415. 183 indexed citations
7.
Putzki, Norman, R. Philip Kinkel, Mariya Dontchev, et al.. (2009). FP39-WE-04 CHAMPIONS extension: 10-year outcomes in interferon beta-1a-treated patients at high risk for developing multiple sclerosis after a clinically isolated syndrome. Journal of the Neurological Sciences. 285. S119–S120. 1 indexed citations
8.
O’Connor, P. & Egon Stenager. (2007). Safety of natalizumab upon re-dosing: Preliminary results from the STRATA study. Multiple Sclerosis Journal. 1 indexed citations
9.
O’Connor, P., M. S. Freedman, Amit Bar‐Or, et al.. (2006). A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses. Neurology. 66(6). 894–900. 269 indexed citations
10.
Dalton, Catherine M., K. A. Miszkiel, P. O’Connor, et al.. (2006). Ventricular enlargement in MS. Neurology. 66(5). 693–698. 33 indexed citations
11.
O’Connor, P., Andrew Goodman, Michele Libonati, et al.. (2004). Randomized multicenter trial of natalizumab in acute MS relapses. Neurology. 62(11). 2038–2043. 117 indexed citations
12.
Ursell, Melanie R., et al.. (2002). A rapid ELISA-based serum assay for myelin basic protein in multiple sclerosis. Journal of Immunological Methods. 262(1-2). 21–27. 21 indexed citations
13.
O’Connor, P. & L. Lee. (1999). Access to multiple sclerosis diagnosis for Canadian neurologists.. PubMed. 26(2). 115–8. 4 indexed citations
14.
Foley‐Nolan, D., M J Kinirons, Robert J. Coughlan, & P. O’Connor. (1990). Post Whiplash Dystonia Well Controlled by Transcutaneous Electrical Nervous Stimulation (TENS). The Journal of Trauma: Injury, Infection, and Critical Care. 30(7). 909–910. 22 indexed citations
15.
Lincoff, Harvey, et al.. (1970). The cryosurgical adhesion. II.. PubMed. 74(1). 98–107. 7 indexed citations
16.
Lincoff, Harvey, A. Nadel, & P. O’Connor. (1970). The Changing Character of the Infected Scleral Implant. Archives of Ophthalmology. 84(4). 421–426. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026